Trial reportJournal of the American Geriatrics Society2018
Economic Evaluation of a Catheter-Associated Urinary Tract Infection Prevention Program in Nursing Homes.
Trial report in Journal of the American Geriatrics Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01062841 (Targeted Infection Control Program), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Targeted Infection Control Program (TIP) to Reduce Resistant Pathogens and Infections
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- A Systematic Review of Economic Evaluations in Clinical Nursing Practices.Journal of nursing management · 2024Pooled it
- Machine Learning Analysis of Risk Factors for Catheter-Associated Urinary Tract Infections in Stroke Patients and Their Impact on Healthcare Quality.International journal of general medicine · 2026Article
- Article
- A systematic review of economic evaluation of healthcare associated infection prevention and control interventions in long term care facilities.Health economics review · 2024Review
- Remote Infection Control Assessments of US Nursing Homes During the COVID-19 Pandemic, April to June 2020.Journal of the American Medical Directors Association · 2022Article
- Exploring nurses' experiences of social media and in-person educational interventions for professional development: a qualitative study.BMC nursing · 2022Article
- Review
- Method for Economic Evaluation of Bacterial Whole Genome Sequencing Surveillance Compared to Standard of Care in Detecting Hospital Outbreaks.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- Prospective Surveillance of Healthcare-Associated Infections in Residents in Four Long-Term Care Facilities in Graz, Austria.Antibiotics (Basel, Switzerland) · 2021Article
- Polymeric Materials with Antibacterial Activity: A Review.Polymers · 2021Review
- Role of Post-Acute Care in Readmissions for Preexisting Healthcare-Associated Infections.Journal of the American Geriatrics Society · 2020Article
Corrections and comments
- Commented on by
Authors and funding
7 authors at 4 institutions in 2 countries.
Funding
Abstract
objectiveTo assess the economic effect and cost effectiveness of a targeted catheter-associated urinary tract infection (CAUTI) prevention intervention in the nursing home (NH) setting.
designRandomized clinical trial.
settingCommunity-based NHs (N=12).
participantsNH residents with indwelling urinary catheters (N=418).
interventionStandard care versus infection prevention program involving barrier precautions, active surveillance, and NH staff education. MEASUREMENTS: Costs of the intervention, costs of disease, and health outcomes were used to calculate an incremental cost-effectiveness ratio for the intervention. Data came from intervention results and the literature and outcomes were analyzed over one year.
resultsA 120-bed NH would have program costs of $20,279/year. The cost of disease treatment would be reduced by $54,316 per year, resulting in a $34,037 net cost savings. Most of this savings would come from fewer CAUTI hospitalizations ($39,180), with $15,136 in savings from CAUTI care within the NH. The intervention also yielded a gain of 0.197 quality-adjusted life-years (QALYs). Taking into account uncertainty in all parameters suggests there is an 85% chance that the intervention is cost-saving.
conclusionsThe CAUTI prevention program is expected to benefit payers by reducing costs and improving health outcomes. Because the savings accrue to payers and not to NHs, payers such as Medicare and private insurers may want to provide incentives for NHs to implement such programs.
trial registrationclinicaltrials.gov Identifier: NCT01062841.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.